Back to Results
First PageMeta Content
Pharmacology / Drug discovery / Pharmaceutical industry / Pharmacy / Animal testing / Medical research / Drug development / Clinical trial / European Federation of Pharmaceutical Industries and Associations / Science / Pharmaceutical sciences / Health


RZ_IPH[removed]007_AWR_englisch.indd
Add to Reading List

Document Date: 2014-10-08 04:05:49

Open Document

File Size: 3,58 MB

Share Result on Facebook

Company

Scientific Progress / /

Continent

Europe / /

Country

Switzerland / Japan / United States / United Kingdom / /

Currency

EUR / /

/

Facility

University of Basel / University of Oxford / /

IndustryTerm

organ systems / project applications / research-based pharmaceutical industry / pharmaceutical industry / software tools / research-based pharmaceutical / pharmaceutical / combination products / chemical structure / chemical alteration / chemical risks / /

MedicalCondition

rare diseases / cancer / HIV / dementia / disease / rheumatoid arthritis / peripheral nervous system disorders / diabetes / pain / lung fibrosis / diseases / multiple sclerosis / infectious diseases / hepatitis / metabolic disorders / respiratory disease / human disease / disorders / tumours / /

MedicalTreatment

antibiotics / /

Organization

University of Basel / Interpharma Association / 3R Research Foundation / European Federation of Pharmaceutical Industries and Associations / European Union / Swiss Centre for Applied Human Toxicology / National Centre of Replacement / Council of States / University of Oxford / Interpharma / /

Person

Sara Käch / Sale III IV / Carolin Lorber Disponible / /

/

Position

author / President / researcher / /

Technology

pharmacokinetics / drug discovery / drug development / MRI / /

URL

www.forschung3r.ch / www.nc3rs.org.uk / /

SocialTag